ETFs Edwards Lifesciences Corporation

EW

US28176E1082

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 05:00:02 15/01/2026 HKT			5-day change	1st Jan Change
83.10 ^USD	-0.88%		-2.04%	-2.52%

01-13	Edwards Lifesciences Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 11:15 AM
01-12	UBS Adjusts Price Target on Edwards Lifesciences to $95 From $92, Maintains Neutral Rating	MT

ETFs positioned on Edwards Lifesciences Corporation

Name	Varia. Jan 1.	Weight	AuM
BMO US PUT WRITE ETF - CAD	+1.05%	2.46%	51 M€
NOMURA NEXT FUNDS INTERNATIONAL EQUITY MSCI-KOKUSAI (YEN-HEDGED) ETF - JPY	+1.01%	2.34%	26 M€
BMO PREMIUM YIELD ETF - CAD	+1.27%	1.17%	227 M€
BMO PREMIUM YIELD ETF - USD	-0.03%	1.17%	30 M€
BMO PREMIUM YIELD ETF - CAD HEDGED	-0.03%	1.17%	27 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD HEDGED	0.00%	1.06%	2 M€
AMUNDI INDEX MSCI USA SRI PAB - UCITS ETF DR (C) - EUR	-.--%	0.94%	0 M€
CSIF (IE) MSCI USA TECH 125 ESG UNIVERSAL BLUE UCITS ETF B - USD	-.--%	0.89%	0 M€
AMUNDI INDEX MSCI WORLD SRI PAB - UCITS ETF DR (C) - EUR	-.--%	0.42%	0 M€
AMUNDI INDEX MSCI WORLD SRI PAB - UCITS ETF DR - HEDGED EUR (C)	-.--%	0.42%	0 M€
FIRST TRUST ALPHADEX U.S. HEALTH CARE SECTOR INDEX ETF - CAD	0.00%	0.36%	5 M€
CSIF (IE) MSCI USA ESG LEADERS BLUE UCITS ETF - B - USD	-.--%	0.36%	0 M€
LYXOR MSCI USA ESG CLIMATE TRANSITION CTB (DR) UCITS ETF - ACC - USD	-.--%	0.34%	0 M€
GOLDMAN SACHS ACTIVEBETA PARIS-ALIGNED SUSTAINABLE US LARGE CAP EQUITY UCITS ETF - USD	+0.55%	0.33%	169 M€
VANECK MULTI-ASSET GROWTH ALLOCATION UCITS ETF - EUR	+1.04%	0.33%	31 M€
VANECK WORLD EQUAL WEIGHT SCREENED UCITS ETF - EUR	+3.64%	0.3%	1,101 M€
AMUNDI MSCI USA ESG LEADERS SELECT - UCITS ETF DR (C) - USD	-0.28%	0.3%	0 M€
LYXOR MSCI USA ESG LEADERS EXTRA (DR) UCITS ETF - ACC - USD	-.--%	0.24%	0 M€
NEXT FUNDS S&P 500 SCORED & SCREENED INDEX ETF - JPY	+8.93%	0.21%	5 M€
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - ACC - USD	+0.01%	0.2%	0 M€

1 2 3 4

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (75.5%); - hemodynamic monitoring systems (6.5%); - other (18%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.9%), Europe (24.3%), Japan (6.3%) and others (10.5%).

Employees

15,800

Sector

Advanced Medical Equipment & Technology

Calendar

02-10 - Q4 2025 Earnings Release

More about the company